FIELD: medicine.
SUBSTANCE: invention relates to medicine, veterinary science and pharmacology, and concerns treating aseptic and freshly infected soft tissue wounds, specifically relates to methods of stimulating regeneration (ability to accelerate and / or induce regeneration processes) of skin and underlying soft tissues, as well as to medicinal agents possessing regenerative potential, and can be used in dermatology, cosmetology and surgery for treating abrasive, full-layer and scalp wounds. Purpose of the invention is to accelerate the process of wound healing with maximum recovery of damaged tissue structures by applying on the wound surface a preparation containing the protein internalin B 321.
EFFECT: method reduces the epithelialization of wounds by activating intracellular signaling pathways leading to accelerated proliferation and cell migration of cells involved in the wound healing process.
2 cl, 5 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRODUCER STRAINS OF VERSIONS OF INTERNALINE 321 RECOMBINANT PROTEINS, GROWTH FACTOR RECEPTOR AGONIST | 2017 |
|
RU2634416C1 |
| METHOD OF DIFFERENTIATING VIRULENT LISTERIA MONOCYTOGENES STRAINS FROM AVIRULENT STRAINS USING POLYCLONAL ANTIBODIES AGAINST PATHOGENICITY FACTORS INTERNALIN A (INLA) AND INTERNALIN B (INLB) | 2023 |
|
RU2808590C1 |
| METHOD OF DIFFERENTIATING LISTERIA MONOCYTOGENES FROM OTHER LISTERIA SPP. DOT BLOT METHOD USING CONJUGATED ANTIBODIES AGAINST INLB PATHOGENICITY FACTOR | 2023 |
|
RU2812147C1 |
| BIS(5-AMINO-1,4-DIOXO-1,2,3,4-TETRAHYDROPHTHALAZIN-2-YL)ZINC, METHOD FOR PRODUCING IT, BASED PHARMACEUTICAL COMPOSITION, BASED THERAPEUTIC AGENTS, METHOD OF TREATING SKIN DISEASES AND METHOD OF TREATING GASTRITIS | 2013 |
|
RU2577849C2 |
| METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
| RECOMBINANT GENE ENCODING HBD-EPO PROTEIN, RECOMBINANT PLASMID DNA PL610, METHOD FOR PRODUCING A RECOMBINANT HBD-EPO PROTEIN, A RECOMBINANT HBD-EPO PROTEIN, A COMPOSITION FOR SPECIFICALLY INDUCING BONE REGENERATION, METHOD OF SPECIFIC INDUCTION OF BONE TISSUE REGENERATION | 2017 |
|
RU2664192C1 |
| RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF | 2015 |
|
RU2682335C2 |
| RECOMBINANT PRODUCER OF HUMAN OMEGA-AMIDASE Nit2 BASED ON ESCHERICHIA COLI | 2016 |
|
RU2642323C2 |
| METHOD OF STIMULATING REPARATIVE ANGIOGENESIS AND REGENERATION OF SKIN OF DOGS WITH DAMAGE THEREOF BY GENE THERAPY USING SPECIES-SPECIFIC GENES OF PROTEIN FACTORS VEGF AND FGF2 IN VETERINARY SCIENCE AND GENETIC CONSTRUCT FOR REALIZING DECLARED METHOD | 2019 |
|
RU2719513C1 |
| RECOMBINANT PLASMID DNA pPA-OPRF-ETA CODING SYNTHESIS OF RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa, STRAIN Escherichia coli PA-OPRF-ETA PRODUCING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa AND METHOD FOR PREPARING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa | 2012 |
|
RU2529359C2 |
